Targeting CD38 with isatuximab and a novel CD38/CD3xCD28 trispecific T-cell engager in older patients with acute myeloid leukemia

被引：2

作者：

Martin-Sanchez, Esperanza ^{[1
]}

Blanco, Laura ^{[1
]}

Kim, Peter S. ^{[2
]}

Bisht, Kamlesh ^{[2
]}

Wang, Hongfang ^{[2
]}

van de Velde, Helgi ^{[2
]}

Jelinek, Tomas ^{[1
,3
,4
]}

Simoes, Catia ^{[1
]}

Prosper, Felipe ^{[1
]}

Miguel, Jesus F. San ^{[1
]}

Alfonso, Ana ^{[1
]}

Bergua, Juan ^{[5
]}

Rodriguez-Veiga, Rebeca ^{[6
]}

Vives, Susana ^{[7
]}

Martinez-Cuadron, David ^{[6
,7
]}

Montesinos, Pau ^{[6
,7
]}

Paiva, Bruno ^{[1
]}

Zabaleta, Aintzane ^{[1
]}

机构：

[1] Clin Univ Navarra, Inst Invest Sanit Navarra, Ctr Invest Med Aplicada, Canc Ctr,CIBER ONC Numbers CB16 12 00369 & CB16 12, Pamplona, Spain

[2] Sanofi R&D, North Amer, Cambridge, MA USA

[3] Univ Ostrava, Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic

[4] Univ Ostrava, Fac Med, Ostrava, Czech Republic

[5] Hosp San Pedro Alcantara, Caceres, Spain

[6] Hosp Univ La Fe, Valencia, Spain

[7] Hosp Germans Trias I Pujol, Josep Carreras Res Inst, Inst Catala Oncol Badalona, Badalona, Spain

来源：

BLOOD ADVANCES | 2024年 / 8卷 / 15期

关键词：

OPEN-LABEL; DEXAMETHASONE; DARATUMUMAB; LENALIDOMIDE; EXPRESSION; TREAT;

D O I：

10.1182/bloodadvances.2024013212

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3875 / 3879

页数：5

共 25 条

[21] Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
Tapia-Galisteo, Antonio
alvarez-Vallina, Luis
Sanz, Laura
[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
[22] How I treat refractory and relapsed acute myeloid leukemia
Thol, Felicitas
Doehner, Hartmut
Ganser, Arnold
[J]. BLOOD, 2024, 143 (01) : 11 - 20
[23] EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
van Dongen, J. J. M.
Lhermitte, L.
Boettcher, S.
Almeida, J.
van der Velden, V. H. J.
Flores-Montero, J.
Rawstron, A.
Asnafi, V.
Lecrevisse, Q.
Lucio, P.
Mejstrikova, E.
Szczepanski, T.
Kalina, T.
de Tute, R.
Brueggemann, M.
Sedek, L.
Cullen, M.
Langerak, A. W.
Mendonca, A.
Macintyre, E.
Martin-Ayuso, M.
Hrusak, O.
Vidriales, M. B.
Orfao, A.
[J]. LEUKEMIA, 2012, 26 (09) : 1908 - 1975
[24] A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia
Vives, Susana
Martinez-Cuadron, David
Bergua Burgues, Juan
Algarra, Lorenzo
Tormo, Mar
Martinez-Sanchez, Maria Pilar
Serrano, Josefina
Herrera, Pilar
Ramos, Fernando
Salamero, Olga
Lavilla, Esperanza
Lopez-Lorenzo, Jose L.
Gil, Cristina
Vidriales, Belen
Falantes, Jose F.
Serrano, Alfons
Labrador, Jorge
Sayas, Maria J.
Foncillas, Maria A.
Amador Barciela, Maria L.
Olave, Maria Teresa
Colorado, Mercedes
Gascon, Adriana
Fernandez, Maria a.
Simiele, Adriana
Perez-Encinas, Manuel M.
Rodriguez-Veiga, Rebeca
Garcia, Olga
Martinez-Lopez, Joaquin
Barragan, Eva
Paiva, Bruno
Sanz, Miguel A.
Montesinos, Pau
[J]. CANCER, 2021, 127 (12) : 2003 - 2014
[25] Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
Wu, Lan
Seung, Edward
Xu, Ling
Rao, Ercole
Lord, Dana M.
Wei, Ronnie R.
Cortez-Retamozo, Virna
Ospina, Beatriz
Posternak, Valeriya
Ulinski, Gregory
Piepenhagen, Peter
Francesconi, Elisa
El-Murr, Nizar
Beil, Christian
Kirby, Patrick
Li, Aiqun
Fretland, Jennifer
Vicente, Rita
Deng, Gejing
Dabdoubi, Tarik
Cameron, Beatrice
Bertrand, Thomas
Ferrari, Paul
Pouzieux, Stephanie
Lemoine, Cendrine
Prades, Catherine
Park, Anna
Qiu, Huawei
Song, Zhili
Zhang, Bailin
Sun, Fangxian
Chiron, Marielle
Rao, Srinivas
Radosevic, Katarina
Yang, Zhi-yong
Nabel, Gary J.
[J]. NATURE CANCER, 2020, 1 (01) : 86 - +

← 1 2 3 →